On the recordJune 8, 2009
we would be naive to consider proposals for regulating and clearing OTC products without also establishing a regulator to protect our markets against systemic risks.
Source
congress.govEditor's note · Context
Ackerman emphasizes the need for a regulator to manage systemic risks in OTC derivatives.
Share
More from Gary Ackerman
May 31, 2012
My inquiry is: Is there a motion before the House or is there a stunt before the House? The SPEAKER pro tempore. The gentleman is not stating a parliamentary inquiry.
Jul 9, 2012
I would divide the camp up into those who want to help the peace process, and then there is a small splinter group of people who are so blinded in their support, trip over themselves, that say we should do everything we have to do to help…
Other voices in this conversation
